Latest period
$11.03B
YoY change
+11.4%
5Y CAGR
+5.4%
Peak year (2025)
$12.42B
Latest annual
$12.42B
Total Debt history chart for Boston Scientific (BSX) from 1991 to 2025
Latest: $12.42B
Total Debt growth chart for Boston Scientific (BSX) from 1991 to 2025
Latest: +11.4%
Total Debt history table for Boston Scientific (BSX) from 1991 to 2025
| 2025 | $12.42B | +11.4% | +$1.27B | ||
| 2024 | $11.15B | +17.4% | +$1.66B | ||
| 2023 | $9.49B | +2.3% | +$210.00M | ||
| 2022 | $9.28B | -1.8% | −$169.00M | ||
| 2021 | $9.45B | -0.9% | −$88.00M | ||
| 2020 | $9.54B | -7.2% | −$738.00M | ||
| 2019 | $10.28B | +46.2% | +$3.25B | ||
| 2018 | $7.03B | +26.0% | +$1.45B | ||
| 2017 | $5.58B | +1.7% | +$94.00M | ||
| 2016 | $5.48B | -3.4% | −$193.00M | ||
| 2015 | $5.68B | +33.2% | +$1.42B | ||
| 2014 | $4.26B | +0.5% | +$22.00M | ||
| 2013 | $4.24B | -0.4% | −$16.00M | ||
| 2012 | $4.26B | -0.1% | −$5.00M | ||
| 2011 | $4.26B | -21.6% | −$1.18B | ||
| 2010 | $5.44B | -8.1% | −$480.00M | ||
| 2009 | $5.92B | -12.3% | −$827.00M | ||
| 2008 | $6.75B | -17.6% | −$1.44B | ||
| 2007 | $8.19B | -8.0% | −$713.00M | ||
| 2006 | $8.90B | +340.7% | +$6.88B | ||
| 2005 | $2.02B | -14.7% | −$347.00M | ||
| 2004 | $2.37B | +37.2% | +$642.00M | ||
| 2003 | $1.73B | +84.5% | +$790.00M | ||
| 2002 | $935.00M | -22.3% | −$269.00M | ||
| 2001 | $1.20B | +44.4% | +$370.00M | ||
| 2000 | $834.00M | -34.7% | −$444.00M | ||
| 1999 | $1.28B | -46.6% | −$1.11B | ||
| 1998 | $2.39B | +384.6% | +$1.90B | ||
| 1997 | $493.50M | +71.5% | +$205.70M | ||
| 1996 | $287.80M | +305.4% | +$216.80M | ||
| 1995 | $71.00M | +64.7% | +$27.90M | ||
| 1994 | $43.10M | +21.4% | +$7.60M | ||
| 1993 | $35.50M | +36.0% | +$9.40M | ||
| 1992 | $26.10M | +3.6% | +$900.00K | ||
| 1991 | $25.20M | — | — |
- 2025$12.42B+11.4%
- 2024$11.15B+17.4%
- 2023$9.49B+2.3%
- 2022$9.28B-1.8%
- 2021$9.45B-0.9%
- 2020$9.54B-7.2%
- 2019$10.28B+46.2%
- 2018$7.03B+26.0%
- 2017$5.58B+1.7%
- 2016$5.48B-3.4%
- 2015$5.68B+33.2%
- 2014$4.26B+0.5%
- 2013$4.24B-0.4%
- 2012$4.26B-0.1%
- 2011$4.26B-21.6%
- 2010$5.44B-8.1%
- 2009$5.92B-12.3%
- 2008$6.75B-17.6%
- 2007$8.19B-8.0%
- 2006$8.90B+340.7%
- 2005$2.02B-14.7%
- 2004$2.37B+37.2%
- 2003$1.73B+84.5%
- 2002$935.00M-22.3%
- 2001$1.20B+44.4%
- 2000$834.00M-34.7%
- 1999$1.28B-46.6%
- 1998$2.39B+384.6%
- 1997$493.50M+71.5%
- 1996$287.80M+305.4%
- 1995$71.00M+64.7%
- 1994$43.10M+21.4%
- 1993$35.50M+36.0%
- 1992$26.10M+3.6%
- 1991$25.20M—
Total Debt values are taken from Boston Scientific's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Debt at Boston Scientific (BSX)
According to Boston Scientific's latest reported financial statements, the company's latest reported total debt is $11.03B. Total debt is the sum of short-term and long-term interest-bearing borrowings on the balance sheet (notes, bonds, term loans, lease liabilities). Useful for leverage and refinancing risk — compare with cash on hand for net leverage, and total liabilities for the broader obligations picture.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Boston Scientific (BSX) most recent annual total debt stands at $12.42B (2025) – grew 11.4% year-over-year.
Across 2020–2025 (5 years), Boston Scientific total debt produced a CAGR of +5.4% – with mixed annual results across the window.
The record annual total debt stands at $12.42B, reached in 2025; the historical low of $25.20M was recorded in 1991.
Boston Scientific Total Debt by Year
Boston Scientific Total Debt 2025: $12.42B
In 2025, Boston Scientific reported total debt of $12.42B, grew 11.4% from 2024. This figure represents the highest annual value in the available history.
Boston Scientific Total Debt 2024: $11.15B
Boston Scientific total debt in 2024 was $11.15B, grew 17.4% from 2023.
Boston Scientific Total Debt 2023: $9.49B
2023's total debt for Boston Scientific came in at $9.49B, edged up 2.3% from 2022.
Boston Scientific Total Debt 2022: $9.28B
Boston Scientific posted total debt of $9.28B in 2022, edged down 1.8% below 2021.
Boston Scientific Total Debt 2021: $9.45B
Boston Scientific total debt in 2021 was $9.45B.
See more financial history for Boston Scientific (BSX).
Sector peers by Total Debt
Healthcare peers of Boston Scientific (BSX), ranked by their latest total debt
| $78.39B | |
| $69.07B | |
| $54.60B | |
| $50.53B | |
| $47.93B | |
| $42.50B | |
| $29.70B | |
| $20.59B |
- $78.39B
- $69.07B
- $54.60B
- $50.53B
- $47.93B
- $42.50B
- $29.70B
- $20.59B
Frequently asked questions
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation